Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ENDO-128-1-13PMID 1670924
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of prolactin secretion and synthesis by dopamine, noradrenaline and pilocarpine in cultured rat pituitary tumour cells.

  2009cited by this paper
• Potassium channels involved in the transduction mechanism of dopamine D2 receptors in rat lactotrophs.

  1989cited by this paper
• Dopamine inhibits cytosolic Ca2+ increases in rat lactotroph cells. Evidence of a dual mechanism of action.

  1987cited by this paper
• Low doses of dopamine agonists in the long-term treatment of macroprolactinomas.

  1985cited by this paper
• Primate cardiovascular responses mediated by dopamine receptors: effects of N,N-di-n-propyldopamine and LY171555.

  1984cited by this paper
• Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state.

  1983cited by this paper
• Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.

  1983cited by this paper
• Polypeptide hormone regulation of gene expression. Thyrotropin-releasing hormone rapidly stimulates both transcription of the prolactin gene and the phosphorylation of a specific nuclear protein.

  1983cited by this paper
• Epidermal growth factor rapidly stimulates prolactin gene transcription

  1982cited by this paper
• Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor

  1981cited by this paper
• Abnormal prolactin responsivity to dopaminergic suppression in hyperprolactinemic patients.

  1981cited by this paper
• Thyrotropin-releasing hormone exerts rapid nuclear effects to increase production of the primary prolactin mRNA transcript.

  1981cited by this paper
• Absence of high affinity dopamine receptor in GH3 cells: a prolactin-secreting clone resistant to the inhibitory action of dopamine.

  1980cited by this paper
• Brain dopamine receptors.

  1980cited by this paper
• Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhibition of cell proliferation

  1980cited by this paper
• Calcium rather than cyclic AMP as the physiological intracellular regulator of prolactin release.

  1980cited by this paper
• Decreased responsiveness of GH3 cells to the dopaminergic inhibition of prolactin.

  1980cited by this paper
• Effect of central nervous system dopaminergic activation on prolactin secretion in man: evidence for a common central defect in hyperprolactinemic patients with and without radiological signs of pituitary tumors.

  1980cited by this paper
• Regulation of prolactin mRNA analyzed using a specific cDNA probe.

  1979cited by this paper
• Epidermal growth factor.

  1979cited by this paper
• Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas

  1979cited by this paper
• Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release.

  1978cited by this paper
• Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system.

  1978cited by this paper
• Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.

  1978cited by this paper
• Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.

  1977cited by this paper
• Control of a cell surface major glycoprotein by epidermal growth factor.

  1977cited by this paper
• Defective dopaminergic regulation of prolactin secretion in a rat pituitary tumour cell line

  1977cited by this paper
• Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes

  1977cited by this paper
• Cultured epithelial cells of cornea, conjunctiva and skin: absence of marked intrinsic divergence of their differentiated states

  1977cited by this paper
• Epidermal growth factor

  1972cited by this paper
• Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization.

  1972cited by this paper
• PRODUCTION OF BOTH PROLACTIN AND GROWTH HORMONE BY CLONAL STRAINS OF RAT PITUITARY TUMOR CELLS

  1970cited by this paper
• Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone.

  1968cited by this paper

• Prolactin Secretion During Postnatal Development in Artificial Rearing Rats (Rattus norvegicus)

  2025cites this paper
• The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas

  2021cites this paper
• EGFR/ErbB2 targeting lapatinib therapy for aggressive prolactinomas.

  2020cites this paper
• Effect of Prunella vulgaris L extract on hyperprolactinemia in vitro and in vivo

  2016cites this paper
• Anti-Hyperprolactinemic Effect of Formula Malt Decoction, a Chinese Herbal Cocktail

  2015cites this paper
• Water Extract of Fructus Hordei Germinatus Shows Antihyperprolactinemia Activity via Dopamine D2 Receptor

  2014cites this paper
• Selected genetic polymorphisms of epidermal growth factor, dopamine-2 receptor, neuregulin-1 and inflammatory cytokines in schizophrenia

  2014cites this paper
• Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors

  2014cites this paper
• Brain gene expression differences are associated with abnormal tail biting behavior in pigs

  2013cites this paper
• Not only dopamine D2 receptors involved in Peony-Glycyrrhiza Decoction, an herbal preparation against antipsychotic-associated hyperprolactinemia.

  2012cites this paper
• Expression and function of ErbB receptors and ligands in the pituitary.

  2011cites this paper
• Tail Biting and Feather Pecking: Using Genomics and Ethology to Explore Motivational Backgrounds

  2011cites this paper
• The role of IGF1 on the differentiation of prolactin secreting cells in the mouse anterior pituitary.

  2009cites this paper
• Temperamental Activity and Epidermal Growth Factor A61G Polymorphism in Finnish Adults

  2008cites this paper
• Epidermal growth factor a61g polymorphism is associated with the age of onset of schizophrenia in male patients.

  2007cites this paper
• Signaling Pathway Involved in the Pro-Apoptotic Effect of Dopamine in the GH3 Pituitary Cell Line

  2006cites this paper
• Individual differences in response to psychological challenge: A study of the effects of EGF A61G and ApoE genetic polymorphisms and temperamental characteristics

  2005cites this paper
• Cloninger's temperament dimensions and epidermal growth factor A61G polymorphism in Finnish adults

  2005cites this paper
• Epidermal growth factor A61G polymorphism and cardiac autonomic control in adults.

  2005cites this paper
• Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation.

  2005cites this paper
• Sumanirole, a Highly Dopamine D2-Selective Receptor Agonist: In Vitro and in Vivo Pharmacological Characterization and Efficacy in Animal Models of Parkinson's Disease

  2005cites this paper
• Pituitary cell lines and their endocrine applications.

  2004cites this paper
• Gene therapy for pituitary tumors: from preclinical models to clinical implementation.

  2003cites this paper
• Induction of mammotroph development by a combination of epidermal growth factor, insulin, and estradiol-17β in rat pituitary tumor GH3 cells

  2002cites this paper
• Mitogen‐Activated Protein Kinase Mediates Epidermal Growth Factor‐Induced Morphogenesis in Pituitary GH3 Cells

  2002cites this paper
• Dopamine as a prolactin (PRL) inhibitor.

  2001cites this paper
• Hypothalamische und hypophysäre Erkrankungen.

  2001cites this paper
• Apoptosis induction by a dopaminergic neurotoxin, 1-methyl-4-phenylpyridinium ion (MPP(+)), and inhibition by epidermal growth factor in GH3 cells.

  2000cites this paper
• Effect of activin on production and secretion of prolactin and growth hormone in cultured rat GH3 cells.

  2000cites this paper
• Epidermal growth factor, insulin, and estrogen stimulate development of prolactin-secreting cells in cultures of GH3 cells

  2000cites this paper
• Prolactin: structure, function, and regulation of secretion.

  2000cites this paper
• Involvement of p38 Mitogen-Activated Protein Kinase Activation in Bromocriptine-Induced Apoptosis in Rat Pituitary GH3 Cells1

  2000cites this paper
• Expression of growth factors in normal and neoplastic pituitary tissues

  2000cites this paper
• Epidermal growth factor (EGF)-induced up-regulation and agonist- and antagonist-induced desensitization and internalization of A1 adenosine receptors in a pituitary-derived cell line.

  1999cites this paper
• Mitogen-activated protein kinase activation by stimulation with thyrotropin-releasing hormone in rat pituitary GH3 cells.

  1999cites this paper
• Growth Factors in Pituitary Tumors

  1999cites this paper
• Gene therapy strategies for the treatment of pituitary tumours.

  1999influential citation
• Dopamine receptors: from structure to function.

  1998cites this paper
• Retinoic Acid Regulates the Developmental Expression of Dopamine D2 Receptor in Rat Striatal Primary Cultures

  1998cites this paper
• Growth factors in the pathogenesis of prolactin-secreting tumors

  1998cites this paper
• Death by a dopaminergic neurotoxin, 1-methyl-4-phenylpyridinium ion (MPP+) and protection by EGF in GH3 cells.

  1998cites this paper
• Nerve growth factor in pituitary development and pituitary tumors.

  1998cites this paper
• D2 Dopamine-Receptor-Mediated Inhibition of Proliferation of Rat Lactotropes in Culture Is Accompanied by Changes in Cell Shape

  1998cites this paper
• Effects of the protein tyrosine kinase inhibitor, herbimycin A, on prolactin gene expression in GH3 and 235-1 pituitary tumor cells.

  1997cites this paper
• Expression of angiotensin II receptor subtypes AT(1A) and AT(1B) in enriched fractions of dispersed rat pituitary cells.

  1997cites this paper
• Epidermal growth factor protects GH3 cells from adenosine induced growth arrest.

  1997cites this paper
• Nerve growth factor suppresses the tumoral phenotype of human prolactinomas.

  1997cites this paper
• Pituitary cytokine and growth factor expression and action.

  1997cites this paper
• Signaling Pathways Modulated by Dopamine Receptors

  1997cites this paper
• Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism.

  1996cites this paper
• Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: a review.

  1996cites this paper
• Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness.

  1996cites this paper
• Induction of classical lactotropes by epidermal growth factor in rat pituitary cell cultures.

  1995cites this paper
• Nerve growth factor promotes the differentiation of pituitary mammotroph cells in vitro.

  1995cites this paper
• Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype.

  1994cites this paper
• A transforming growth factor-alpha pathway is expressed in GH4C1 rat pituitary tumors and appears necessary for tumor formation.

  1994cites this paper
• Heterologous expression of G protein-linked receptors in pituitary and fibroblast cell lines.

  1994cites this paper
• Human pituitary somatotropes express transforming growth factor-alpha and its receptor.

  1994cites this paper
• [Etiopathogenesis of pituitary tumors].

  1994cites this paper
• Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas.

  1994cites this paper
• Transcription of the rat dopamine-D2-receptor gene from two promoters.

  1994cites this paper
• Epidermal growth factor treatment induces D2 dopamine receptors functionally coupled to delayed outward potassium current (IK) in GH4C1 clonal anterior pituitary cells.

  1994cites this paper
• Efficacy of Intrastriatal Transplants: Role of Trophic Factors

  1994cites this paper
• Bioactive peptides in anterior pituitary cells.

  1994cites this paper
• Epidermal Growth Factor Promotes Uncoupling from Adenylyl Cyclase of the Rat D2S Receptor Expressed in GH4C1 Cells

  1994cites this paper
• Effects of Estrogen and Epidermal Growth Factor on Prolactin and Pit-1 mRNA in GH3 Cells

  1993cites this paper
• Further characterization of the D2 dopamine receptor expressed in MMQ cells.

  1993cites this paper
• Nerve growth factor suppresses the transforming phenotype of human prolactinomas.

  1993cites this paper
• 10 – Non-IGF Growth Factors That Mediate Cell Proliferation and Differentiation

  1993cites this paper
• Presence of growth factors in human pituitary.

  1992cites this paper
• Effects of coculture of anterior and posterior pituitary cells on the responsiveness of lactotrophs to different secretagogues.

  1991cites this paper
• Pharmacological and molecular basis for dopamine D-2 receptor diversity

  1990cites this paper